QFQuanxin Feng

Quanxin Feng

*This is an algorithmically generated author record based on publicly available information.

Quanxin Feng has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Bai

    State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, 127 Changle Western Road, Xi'an, Shaanxi, 710032, China

    5 shared publications
  • Qingchuan Zhao

    Department of Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi Province, 710000, PR China

    5 shared publications
  • Pengfei Yu

    State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, 127 Changle Western Road, Xi'an, Shaanxi, 710032, China

    4 shared publications
  • Shiqi Wang

    Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, The First Affiliated Hospital of Fourth Military Medical University (Xijing Hospital), Fourth Military Medical University, Xi'an, China

    4 shared publications
  • Bin Xu

    State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases, The Fourth Military Medical University 127 Changle Western Road, Xi'an, Shaanxi Province 710032, China

    3 shared publications
  • Xiangying Feng

    Department of Intensive Care Unit, Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, 127 Changle Western Road, Xi'an, Shaanxi, 710032, China

    3 shared publications

Latest Publications

  • Effects of Early Versus Delayed Feeding in Patients With Acute Pancreatitis

    by Xi-Ying Liang, Xin-An Mb Wu, Ying Mb Tian, Hang Mb Gao, Jing-Jing Mb Chen, Quan-Xin Feng

    Background: The aim of this study was to summarize the optimal strategy for early feeding in patients with acute pancreatitis. Methods: The search was undertaken in electronic databases, which compared early with delayed feeding in acute pancreatitis. The primary outcome was the length of hospital stay (LOHS). The second outcomes were intolerance of refeeding, mortality, and total cost of each patient. This meta-analysis followed the “Preferred Reporting Items for Systematic Reviews and Meta-analyses” guideline. Research is registered by PROSPERO, CRD42020192133. Results: A total of 20 trials involving 2168 patients were included, randomly assigned to the early feeding group (N = 1033) and delayed feeding group (N = 1135). The LOHS was significantly lower in the early feeding group than the delayed feeding group (mean difference: −2.35, 95% CI: −2.89 to −1.80; P < 0.0001), no matter the mild or severe subgroup (P int = 0.69). The secondary outcome of feeding intolerance and mortality were no significant difference (risk ratio: 0.96, 0.40 to 2.16, P = 0.87 and 0.91, 0.57 to 1.46, P = 0.69; respectively). Moreover, the hospitalization cost was significantly less in the early feeding group, resulting in an average savings of 50%. In patients with severe pancreatitis, early feeding after 24 hours may be beneficial (P int = 0.001). Conclusion: Early oral feeding can significantly reduce the LOHS and hospitalization costs in patients with acute pancreatitis without increasing feeding intolerance or mortality. In patients with severe pancreatitis, early feeding after 24 hours may be beneficial.


  • Efficacy of resistin and leptin in predicting persistent organ failure in patients with acute pancreatitis

    by Pengfei Yu, Shiqi Wang, Zhaoyan Qiu, Bin Bai, Zhanwei Zhao, Yiming Hao, Qian Wang, Min Guo, Xiangying Feng, Junjie Zhu, et al.


  • Regulatory B10 cells play a protective role in severe acute pancreatitis

    by Zhaoyan Qiu, Pengfei Yu, Bin Bai, Yiming Hao, Shiqi Wang, Zhanwei Zhao, Zhenning Hang, Qian Wang, Min Guo, Quanxin Feng, et al.

    Background B10 cells are specific B cell subsets with the capacity of producing IL-10 to inhibit immune responses. Several studies have demonstrated that B10 cells are correlated with some immune and inflammatory diseases, such as experimental autoimmune encephalomyelitis (EAE), collagen-induced arthritis (CA), colitis and contact hypersensitivity. However, its role in severe acute pancreatitis (SAP) has not been clearly demonstrated yet. Purpose In this study, we show that B10 cells can inhibit inflammation of severe acute pancreatitis (SAP). Materials and methods Blood from 17 patients with SAP and 22 age-matched healthy volunteers were collected to detect the proportion of B10 cells. CD19−/− mice were used as B10 cell-deficient mice. Amylase and lipase levels, pancreatic edema and HE staining were tested to assess the severity of SAP. Results CD19−/− mice, which lack B10 cells, suffered a more severe inflammation in pancreas compared with wild-type mice after caerulein injection. The frequency of B10 cells was decreased both in SAP patients and SAP animal models. Adoptive transfer of B10 cells ameliorates inflammatory injury of pancreatitis in CD19−/− mice. Conclusion Thus, we identified B10 cells as a protective factor for SAP and provided a novel target for SAP treatment.


    • 15 June 2014
      • Vol. 7  (7) , 3620-31

    Interleukin-1β induces autophagy by affecting calcium homeostasis and trypsinogen activation in pancreatic acinar cells.

    by Bin Xu, Bin Bai, Sumei Sha, Pengfei Yu, Yanxin An, Shiqi Wang, Xiangyun Kong, Chaoxu Liu, Ni Wei, Quanxin Feng, et al.

    The strong up-regulation of inflammatory mediators has been reported to play a key role in acute pancreatitis (AP). Elevated serum levels of interleukin-1β (IL-1β) are associated with the development of AP. However, the precise effect and mechanism of IL-1β in AP remains obscure. In this study, we investigated the potential role and mechanism of IL-1β in AP. We measured autophagy activation in response to IL-1β in AR42J cells. The disrupting effects of IL-1β on cellular Ca(2+) were observed. To determine whether the disruption of Ca(2+) signaling has protective effects in vivo during AP, male C57BL/6 mice were treated with cerulein to induce AP. We found that the treatment of AR42J cells with IL-1β triggered autophagy and that the autophagic flux was impaired. In addition, IL-1β induced Ca(2+) release from the ER. Furthermore, the expression of the ER stress markers GRP78 and IRE1 also increased. 2APB, an antagonist of the InsP3 receptor, inhibited increased expression of autophagy markers. Subsequent biochemical assays revealed that co-culture with IL-1β could induce the activation of trypsinogen to trypsin and reduce the viability of acinar cells. Pathological changes of the pancreas were also observed in vivo. We found that the pathological injuries of the pancreas were significantly alleviated in mice co-treated with 2APB. Taken together, our results indicate that IL-1β can induce trypsin activation and decrease cellular viability in pancreatic acinar cells. These effects depend on impaired autophagy via intracellular calcium changes. Ca(2+) signaling may become a promising therapeutic target in the treatment of pancreatitis.


  • The ability of current scoring systems in differentiating transient and persistent organ failure in patients with acute pancreatitis

    by Shiqi Wang, Xiangying Feng, Shujun Li, Chaoxu Liu, Bin Xu, Bin Bai, Pengfei Yu, Quanxin Feng, Qingchuan Zhao


  • Early Classic Hemofiltration Exhibits No Benefits in Severe Acute Pancreatitis With Early Organ Failure: A Retrospective Case-Matched Study

    by Xujie Zhang, Shiren Sun, Shujun Li, Xiangying Feng, Shiqi Wang, ChaoXu Liu, Zhenning Hang, Chao Tong, Cailin Zhu, Bin Bai, et al.

    Continuous venovenous hemofiltration (CVVH) is an important organ supportive technique. This study aimed to evaluate the impact of early classic CVVH on the outcomes of severe acute pancreatitis (SAP) patients with early organ failure (EOF). Between 2008 and 2012, a total of 44 SAP patients with EOF were admitted to our department. The 44 patients were classified into two groups according to whether they received early classic CVVH (2 L/h, initiated within 24 h after admission): 25 patients received early CVVH (ECVVH group), and 19 patients did not receive early CVVH (control group). The two groups were matched for age and Acute Physiology and Chronic Health Evaluation II scores. The severity of organ dysfunctions was evaluated by Sequential Organ Failure Assessment (SOFA) scores. Each group included 19 patients. The baseline characters between the two groups were balanced. The SOFA scores in the ECVVH group increased compared with those in the control group. The time to weaning from mechanical ventilation was significantly longer in the ECVVH group (log‐rank test: χ2 = 4.007, P = 0.045). Renal support was also significantly prolonged in the ECVVH group (the number of patients receiving CVVH 72 h after admission: 10 vs. 3, respectively, P = 0.038). Nine patients died in the ECVVH group versus six patients in the control group (P = 0.508). In conclusion, our study failed to prove that early classic CVVH had any benefits on the outcomes of SAP patients with EOF. Unexpectedly, early classic CVVH worsened organ functional capacity. However, it is possible that CVVH using advanced techniques may be beneficial in SAP patients with EOF.